Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada

Abstract

The proportion of overweight and obese adults in the United States and Canada has increased over the past decade, but temporal trends in body mass index (BMI) and weight gain on antiretroviral therapy (ART) among HIV-infected adults have not been well characterized. We conducted a cohort study comparing HIV-infected adults in the North America AIDS Cohort Collaboration on Research and Design (NA-ACCORD) to United States National Health and Nutrition Examination Survey (NHANES) controls matched by sex, race, and age over the period 1998 to 2010. Multivariable linear regression assessed the relationship between BMI and year of ART initiation, adjusting for sex, race, age, and baseline CD4⁺ count. Temporal trends in weight on ART were assessed using a generalized least-squares model further adjusted for HIV-1 RNA and first ART regimen class. A total of 14,084 patients from 17 cohorts contributed data; 83% were male, 57% were nonwhite, and the median age was 40 years. Median BMI at ART initiation increased from 23.8 to 24.8 kg/m² between 1998 and 2010 in NA-ACCORD, but the percentage of those obese (BMI ≥30 kg/m²) at ART initiation increased from 9% to 18%. After 3 years of ART, 22% of individuals with a normal BMI (18.5–24.9 kg/m²) at baseline had become overweight (BMI 25.0–29.9 kg/m²), and 18% of those overweight at baseline had become obese. HIV-infected white women had a higher BMI after 3 years of ART as compared to age-matched white women in NHANES (p = 0.02), while no difference in BMI after 3 years of ART was observed for HIV-infected men or non-white women compared to controls. The high prevalence of obesity we observed among ART-exposed HIV-infected adults in North America may contribute to health complications in the future.

Get full access to this article

View all access options for this article.

References

The State of Obesity 2014: Robert Wood Johnson Foundation; 2014. Available at http://stateofobesity.org/files/stateofobesity2014.pdf.

Adult Obesity Prevalence in Canada and the United States: NCHS data brief, no. 56. National Center for Health Statistics, Hyattsville, MD, 2011.

Statistics Canada: Measured adult body mass index (BMI) by age group and sex, household population age 18 and over excluding pregnant females, Canada (excluding territories). (CANSIM table 105-0507.) Statistics Canada, Ottawa, 2009.

Crum-Cianflone

, Roediger

, Eberly

, et al.: Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One, 2010; 5:e10106.

Amorosa

, Synnestvedt

, Gross

, et al.: A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr, 2005; 39:557–561.

Tate

, Willig

, et al.: HIV infection and obesity: Where did all the wasting go?. Antivir Ther, 2012; 17:1281–1289.

Taylor

, Liang

, Garduno

, et al.: High risk of obesity and weight gain for HIV-infected uninsured minorities. J Acquir Immune Defic Syndr, 2014; 65:e33–40.

Kim

, Westfall

, Chamot

, et al.: Multimorbidity patterns in HIV-infected patients: The role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr, 2012; 61:600–605.

Mulligan

, Harris

, Monte

, et al.: Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. Clin Infect Dis, 2010; 50:106–114.

10.

McCutchan

, Marquie-Beck

, Fitzsimons

, et al.: Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology, 2012; 78:485–492.

11.

Berrahmoune

, Herbeth

, Samara

, et al.: Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: The Stanislas study. Int J Obes (Lond), 2008; 32:1279–1288.

12.

Fransson

, Batty

, Tabak

, et al.: Association between change in body composition and change in inflammatory markers: An 11-year follow-up in the Whitehall II Study. J Clin Endocrinol Metab, 2010; 95:5370–5374.

13.

Alley

and Chang

: Metabolic syndrome and weight gain in adulthood. J Gerontol A Biol Sci Med Sci, 2010; 65:111–117.

14.

Chan

, Rimm

, Colditz

, et al.: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care, 1994; 17:961–969.

15.

Gange

, Kitahata

, Saag

, et al.: Cohort profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol, 2007; 36:294–301.

16.

National Heart, Lung, and Blood Institute (NHLBI): The Evidence Report: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Department of Health and Human Services, National Heart, Lung, and Blood Institute, Bethesda, MD. NIH Publication No. 98-4083, 1998.

17.

Harrell

: Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer-Verlag, New York, 2001.

18.

Johnson

, Paulose-Ram

, Ogden

, et al.: National Health and Nutrition Examination Survey: Analytic Guidelines, 1999–2010. Vital and Health Statistics Reports Series, 2, 2013.

19.

Tedaldi

, Brooks

, Weidle

, et al.: Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr, 2006; 43:35–41.

20.

Buchacz

, Baker

, Palella

Jr , et al.: Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther, 2013; 18:65–75.

21.

McCormick

, Francis

, Iliffe

, et al.: Increasing obesity in treated female HIV patients from Sub-Saharan Africa: Potential causes and possible targets for intervention. Front Immunol, 2014; 5:507.

22.

Hodgson

, Ghattas

, Pritchitt

, et al.: Wasting and obesity in HIV outpatients. AIDS, 2001; 15:2341–2342.

23.

Lakey

, Yang

, Yancy

, et al.: From wasting to obesity: Initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Res Hum Retroviruses, 2013; 29:435–440.

24.

Lloyd-Jones

, Adams

, Brown

, et al.: Heart disease and stroke statistics–2010 update: A report from the American Heart Association. Circulation, 2010; 121:e46–e215.

25.

Swinburn

, Sacks

, and Ravussin

: Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr, 2009; 90:1453–1456.

26.

Westerterp

and Speakman

: Physical activity energy expenditure has not declined since the 1980s and matches energy expenditures of wild mammals. Int J Obes (Lond), 2008; 32:1256–1263.

27.

Craig

, Russell

, Cameron

, and Bauman

:. Twenty-year trends in physical activity among Canadian adults. Can J Public Health, 2004; 95:59–63.

28.

Macallan

, Noble

, Baldwin

, et al.: Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med, 1995; 333:83–88.

29.

Powanda

and Beisel

: Metabolic effects of infection on protein and energy status. J Nutr, 2003; 133:322S–327S.

30.

Koethe

, Bian

, Shintani

, et al.: An association between adiposity and serum levels of macrophage inflammatory protein-1alpha and soluble CD14 in HIV-infected adults: Results from a cross-sectional study. Antivir Ther, 2013; 18:729–733.

31.

Brown

, Tassiopoulos

, Bosch

, et al.: Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care, 2010; 33:2244–2249.

32.

Duprez

, Neuhaus

, Kuller

, et al.: Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One, 2012; 7:e44454.

33.

Triant

, Meigs

, and Grinspoon

: Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr, 2009; 51:268–273.

34.

Kuller

, Tracy

, Belloso

, et al.: Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med, 2008; 5:e203.

35.

De Wit

, Sabin

, Weber

, et al.: Incidence and risk factors for new-onset diabetes in HIV-infected patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care, 2008; 31:1224–1229.

36.

Koethe

, Jenkins

, Turner

, et al.: Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy. HIV Med, 2015; 16:67–72.

37.

Boodram

, Plankey

, Cox

, et al.: Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study. AIDS Patient Care STDS, 2009; 23:1009–1016.

38.

Jones

, Hogan

, Snyder

, et al.: Overweight and human immunodeficiency virus (HIV) progression in women: Associations of HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis, 2003; 37(Suppl 2):S69–80.

39.

Koethe

, Hulgan

, and Niswender

: Adipose tissue and immune function: A review of evidence relevant to HIV infection. J Infect Dis, 2013; 208:1194–1201.

40.

Stanley

and Grinspoon

: Body composition and metabolic changes in HIV-infected patients. J Infect Dis, 2012; 205(Suppl 3):S383–390.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

0.03 MB